Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Operable Breast Cancer”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Large-scale testing (Phase 3)UnknownNCT01019616
What this trial is testing

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Who this might be right for
Primary Breast Cancer
Tao OUYANG 400
Large-scale testing (Phase 3)Study completedNCT00003013
What this trial is testing

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 450
Testing effectiveness (Phase 2)Study completedNCT00203502
What this trial is testing

Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Arkansas 40
Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Testing effectiveness (Phase 2)Study completedNCT02488564
What this trial is testing

Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 49
Large-scale testing (Phase 3)Study completedNCT01358877
What this trial is testing

Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 4,804
Not applicableLooking for participantsNCT06830590
What this trial is testing

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Who this might be right for
Breast CancerMolecular Pathway DeregulationTreatment
Liaquat University of Medical & Health Sciences 300
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Testing effectiveness (Phase 2)Active Not RecruitingNCT00616967
What this trial is testing

Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 68
Large-scale testing (Phase 3)Study completedNCT04127019
What this trial is testing

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

Who this might be right for
Primary Breast Cancer
Fudan University 2,079
Testing effectiveness (Phase 2)Ended earlyNCT01985841
What this trial is testing

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 34
Testing effectiveness (Phase 2)WithdrawnNCT00434031
What this trial is testing

CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute, Naples
Large-scale testing (Phase 3)Study completedNCT00123669
What this trial is testing

Primary Progesterone Therapy for Operable Breast Cancer

Who this might be right for
Breast Neoplasms
Tata Memorial Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT03395899
What this trial is testing

Pre-operative Immunotherapy Combination Strategies in Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
Queen Mary University of London 71
Large-scale testing (Phase 3)Study completedNCT01314833
What this trial is testing

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Who this might be right for
Primary Breast Cancer
Fudan University 1,570
Large-scale testing (Phase 3)Study completedNCT01966471
What this trial is testing

Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 1,846
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Testing effectiveness (Phase 2)Study completedNCT00256360
What this trial is testing

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 117
Testing effectiveness (Phase 2)Ended earlyNCT00148720
What this trial is testing

Capecitabine in Women With Operable Breast Cancer

Who this might be right for
Invasive Breast CarcinomaPrimary Invasive Breast CancerStage I Breast Cancer+2 more
Dana-Farber Cancer Institute 80
Next Page